İçeriğe geç
akaturk Akademik ölçüm

OpenAlex konusu

Chemotherapy-induced cardiotoxicity and mitigation

Bu sayfa OpenAlex konu etiketine göre çalışmaları ve o konuda görünen akademisyenleri listeler. YÖKSİS temel alan / yan dal değildir.

OpenAlex 1.579 eser 42 yazar konusu

Çalışmalar

1.579 eser

  1. YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.4%

    Özet henüz yok.

  2. YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.4%

    Özet henüz yok.

  3. YÖKSİS SJR Q2 JCR Q1 OpenAlex üst %10 OpenAlex 98.8%

    Özet henüz yok.

  4. OpenAlex üst %1 OpenAlex 100.0%

    BACKGROUND: The first clinical study of paclitaxel-eluting stent for de novo lesions showed promising results. We performed the TAXUS III trial to evaluate the feasibility and safety of paclitaxel-eluting stent for the treatment of in-stent restenosis (ISR). METHODS AND RESULTS: The TAXUS III trial was a single-arm, 2…

  5. YÖKSİS OpenAlex üst %10 OpenAlex 92.9%

    Özet henüz yok.

  6. YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.7%

    AIMS: The protective effect of beta-blockers, ACE inhibitors, and ARBs on anthracycline cardiotoxicity has already been demonstrated, but the effect of aldosterone antagonism, which inhibits the last step of the renin-angiotensin-aldosterone system (RAAS), was questioned. This study sought to investigate whether spiro…

  7. YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.7%

    AIMS: The protective effect of beta-blockers, ACE inhibitors, and ARBs on anthracycline cardiotoxicity has already been demonstrated, but the effect of aldosterone antagonism, which inhibits the last step of the renin-angiotensin-aldosterone system (RAAS), was questioned. This study sought to investigate whether spiro…

  8. YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 94.7%

    Özet henüz yok.

  9. YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 94.7%

    Özet henüz yok.

  10. YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 96.2%

    Özet henüz yok.

  11. YÖKSİS SJR Q2 JCR Q4 OpenAlex üst %1 OpenAlex 99.2%

    Curcumin is a phytochemical isolated from Curcuma longa with potent tumor-suppressor activity, which has shown significant efficacy in pre-clinical and clinical studies. Curcumin stimulates cell death, triggers cycle arrest, and suppresses oncogenic pathways, thereby suppressing cancer progression. Cisplatin (CP) stim…

  12. YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 99.0%

    Özet henüz yok.

Akademisyenler

42 akademisyen